Lamia Aljundi in Flint, Michigan

Home Michigan Flint

Lamia Aljundi has Pulmonary Disease as her primary medical specialty. Their primary office is: G3252 Beecher Rd in Flint, Michigan. There are 2 additional office locations for Lamia Aljundi that can be viewed towards the end of their profile.

They're a part of the: Pulmonary Associates, Pc medical group which has around 10 members. You can call their office at 810-230-6800 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2014 (around 10 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Lamia Aljundi Office Phone and Directions

Lamia Aljundi
Pulmonary Associates, Pc
G3252 Beecher Rd
Flint, Michigan 48532
810-230-6800

Patient Ratings
Please rate your experience with Lamia Aljundi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 810-230-6800

Enter a starting address:

Healthcare Info for Lamia Aljundi

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Sorry, her university is not listed
Graduation Year: 2014
The Primary Medical Specialty for Lamia Aljundi is listed as: Pulmonary Disease
Approximate Years of Experience: 10
PAC (PECOS ID)#: 6002101755
NPI #: 1780030619
NPI Created On: 05/10/2016
NPI Last Updated Listed as: 09/20/2022
Primary Taxonomy Code: 207R00000X
License Number:
4301109522
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $105

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839140007

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: ORENITRAM

Open Associated Drug #1: 66302-302-01

Payments Total: $22

Number of Payments:: 1